32 recovered patients donate plasma to others with coronavirus infection


Thirty-two patients who have recovered from the novel coronavirus had donated 10,650 ml of plasma by Saturday, said China National Biotec Group, a state-owned biological products maker.
The donation came one day after the company announced on Friday that it has developed convalescent plasma to treat patients with novel coronavirus pneumonia.
The current treatment of novel coronavirus pneumonia lacks vaccines and specific drugs, but recovered patients’ plasma has been put into clinical treatment which achieved initial results.
The company said they have set up a special team to collect plasma from recovered patients in Wuhan, Central China’s Hubei province, since Jan 20.
On Feb 8, three critically ill patients in a hospital in the Jiangxia District of Wuhan received plasma treatment. More than 10 critical patients received the treatment so far, the company said.
The clinical results showed that patients’ clinical symptoms have improved significantly 12 to 24 hours after the treatment, with inflammatory indicators in the laboratory decreasing significantly and some key indicators, such blood oxygen saturation, showingn promising results.
Convalescent plasma has also been proved effective in the treatment of severe acute respiratory syndrome and Ebola virus disease.
- PhD graduate from EU shares insight about studying in China
- Train attendants receive etiquette training in Chongqing
- Former senior customs official indicted for graft
- From peasant uprising to industrial revolution: hero's hometown revived
- Workers weather desert extremes to complete 'power expressway loop' in southern Xinjiang
- China issues guidelines highlighting independent, impartial judicial work